BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 630463)

  • 1. Clinical evaluation of porcine heterograft cardiac valves in 200 patients.
    Jamieson WR; Munro AI; Miyagishima RT; Allen P
    Can J Surg; 1978 Mar; 21(2):133-5. PubMed ID: 630463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgical treatment of acquired heart defects].
    Tsukerman GI; Semenovskiĭ ML; Bykova VA; Il'ina VE; Kosach GA
    Grudn Khir; 1978; (5):22-31. PubMed ID: 700429
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors affecting performance and thromboembolism after porcine xenograft cardiac valve replacement.
    Geha AS; Hammond GL; Laks H; Stansel HC; Glenn WW
    J Thorac Cardiovasc Surg; 1982 Mar; 83(3):377-84. PubMed ID: 7062749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-year follow-up of glutaraldehyde-preserved heterografts. With particular reference to the treatment of congenital valve malformations.
    Carpentier A; Deloche A; Relland J; Fabiani JN; Forman J; Camilleri JP; Soyer R; Dubost C
    J Thorac Cardiovasc Surg; 1974 Nov; 68(5):771-82. PubMed ID: 4214526
    [No Abstract]   [Full Text] [Related]  

  • 5. Long term clinical and haemodynamic evaluation of the Ionescu-Shiley pericardial xenograft heart valve.
    Ionescu MI; Tandon AP
    Thoraxchir Vask Chir; 1978 Aug; 26(4):250-8. PubMed ID: 694896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart valve replacement with the Hancock bioprosthesis. Analysis of long-term results.
    Cévese PG; Gallucci V; Morea M; Dalla Volta S; Fasoli G; Casarotto D
    Circulation; 1977 Sep; 56(3 Suppl):II111-6. PubMed ID: 407032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with surgery of the heart valves.
    Björk VO
    Ann Chir Gynaecol; 1976; 65(2):75-81. PubMed ID: 962282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An eight-year experience with porcine bioprosthetic cardiac valves.
    Hartz RS; Fisher EB; Finkelmeier B; DeBoer A; Sanders JH; Moran JM; Michaelis LL
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):910-7. PubMed ID: 3713240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 5 1/2 year experience with the St. Jude Medical cardiac valve prosthesis. Early and late results of 737 valve replacements in 671 patients.
    Baudet EM; Oca CC; Roques XF; Laborde MN; Hafez AS; Collot MA; Ghidoni IM
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):137-44. PubMed ID: 3874324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term evaluation of tissue valves.
    Ionescu MI; Pakrashi BC; Mary DA; Bartek IT; Wooler GH; McGoon DC
    J Thorac Cardiovasc Surg; 1974 Sep; 68(3):361-79. PubMed ID: 4853033
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac valve replacement. A seven-year follow-up.
    Aston SJ; Mulder DG
    J Thorac Cardiovasc Surg; 1971 Apr; 61(4):547-55. PubMed ID: 5549110
    [No Abstract]   [Full Text] [Related]  

  • 12. [Replacement of human heart valves with heterologous aortic transplants].
    Ionescu MI; Wooler GH
    Thoraxchir Vask Chir; 1968 Dec; 16(6):606-14. PubMed ID: 5255138
    [No Abstract]   [Full Text] [Related]  

  • 13. Valve replacement surgery in patients with end-stage renal disease: long-term results.
    Gultekin B; Ozkan S; Uguz E; Atalay H; Akay T; Arslan A; Sezgin A; Ozdemir N; Tasdelen A; Aslamaci S
    Artif Organs; 2005 Dec; 29(12):972-5. PubMed ID: 16305653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Replacement of the mitral and aortic valves with bioprostheses. Long-term results].
    Colombo T; Cicardi C; Peronace B; Pozzi M; Gordini V; Pellegrini A
    G Ital Cardiol; 1985 Oct; 15(10):974-82. PubMed ID: 4092917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late incidence and determinants of stroke after aortic and mitral valve replacement.
    Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
    Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis.
    Aramendi JL; Agredo J; Llorente A; Larrarte C; Pijoan J
    J Heart Valve Dis; 1998 Nov; 7(6):610-4. PubMed ID: 9870193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The St. Jude Medical bileaflet valve prosthesis. A 5 year experience.
    Chaux A; Czer LS; Matloff JM; DeRobertis MA; Stewart ME; Bateman TM; Kass RM; Lee ME; Gray RJ
    J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):706-17. PubMed ID: 6492839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term results of triple valve surgery in the modern era.
    Alsoufi B; Rao V; Borger MA; Maganti M; Armstrong S; Feindel CM; Scully HE; David TE
    Ann Thorac Surg; 2006 Jun; 81(6):2172-7; discussion 2177-8. PubMed ID: 16731149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
    Mykén PS
    J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
    Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.